Form 4: J.H. Whitney Equity Partners VII, LLC Reports Sale of Aveanna Healthcare Holdings Shares
SEC Form 4
J.H. Whitney Equity Partners VII, LLC, a 10% owner of Aveanna Healthcare Holdings, Inc., reported the sale of common stock through a pre-arranged Rule 10b5-1 trading plan.
Summary
- J.H. Whitney Equity Partners VII, LLC filed a Form 4 detailing the sale of Aveanna Healthcare Holdings, Inc. (AVAH) common stock.
- The sales occurred on March 24 and March 25, 2025, at weighted average prices of $5.63 and $5.64 per share, respectively.
- The sales were executed automatically under a Rule 10b5-1 trading plan adopted on December 13, 2024.
- The shares were sold by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC.
- After the reported transactions, J.H. Whitney VII, L.P. beneficially owns 31,387,870 shares, PSA Healthcare Investment Holding LLC beneficially owns 15,681,716 shares, and PSA Iliad Holdings LLC beneficially owns 1,451,765 shares.
- J.H. Whitney Equity Partners VII, LLC is the general partner of J.H. Whitney VII, L.P. and may be deemed to share voting and dispositive power.
- Strategic Partners VII is the managing member of PSA Healthcare and PSA Iliad Holdings and may be deemed to share voting and dispositive power.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a pre-planned sale of shares. It doesn't necessarily indicate a negative outlook on the company, but it doesn't provide any positive signals either.
Risks
- The Form 4 filing indicates a sale of shares by a significant shareholder, which could be perceived negatively by the market.
Industry Context
Sales by major shareholders are common and often pre-planned, especially through Rule 10b5-1 plans, to avoid accusations of insider trading. The impact on the stock price depends on the size of the sale relative to the trading volume and overall market sentiment.
Comparison to Industry Standards
- It's common for large shareholders, especially private equity firms like J.H. Whitney, to periodically reduce their holdings in publicly traded companies.
- Rule 10b5-1 plans are a standard tool used by insiders to sell shares over time without raising concerns about trading on non-public information.
- The reported sales are relatively small compared to the total shares outstanding, suggesting a gradual reduction in ownership rather than a complete exit.
Stakeholder Impact
- The sale of shares could have a minor negative impact on shareholder value if the market perceives it as a lack of confidence from a major shareholder.
Key Dates
| Date | Description |
|---|---|
| 2024-12-13 | Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, and PSA Iliad Holdings LLC. |
| 2025-03-24 | Sale of common stock at a weighted average price of $5.63. |
| 2025-03-25 | Sale of common stock at a weighted average price of $5.64. |
| 2025-03-26 | Date of the Confirming Statement signed by Robert M. Williams. |
Keywords
Aveanna Healthcare Holdings, AVAH, J.H. Whitney Equity Partners VII, Form 4, share sale, Rule 10b5-1, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.